IB Acquisition (IBAC) Competitors $10.19 +0.01 (+0.10%) As of 01/17/2025 01:19 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends IBAC vs. GAMI, FPI, PBT, CHCT, GMRE, VINP, ANSC, NLOP, NETD, and BIOXShould you be buying IB Acquisition stock or one of its competitors? The main competitors of IB Acquisition include GAMCO Investors (GAMI), Farmland Partners (FPI), Permian Basin Royalty Trust (PBT), Community Healthcare Trust (CHCT), Global Medical REIT (GMRE), Vinci Partners Investments (VINP), Agriculture & Natural Solutions Acquisition (ANSC), Net Lease Office Properties (NLOP), Nabors Energy Transition Corp. II (NETD), and Bioceres Crop Solutions (BIOX). These companies are all part of the "trading" industry. IB Acquisition vs. GAMCO Investors Farmland Partners Permian Basin Royalty Trust Community Healthcare Trust Global Medical REIT Vinci Partners Investments Agriculture & Natural Solutions Acquisition Net Lease Office Properties Nabors Energy Transition Corp. II Bioceres Crop Solutions GAMCO Investors (NYSE:GAMI) and IB Acquisition (NASDAQ:IBAC) are both small-cap finance companies, but which is the better business? We will contrast the two businesses based on the strength of their community ranking, analyst recommendations, dividends, profitability, risk, earnings, valuation, institutional ownership and media sentiment. Does the media favor GAMI or IBAC? In the previous week, GAMCO Investors had 2 more articles in the media than IB Acquisition. MarketBeat recorded 2 mentions for GAMCO Investors and 0 mentions for IB Acquisition. IB Acquisition's average media sentiment score of 1.46 beat GAMCO Investors' score of 1.35 indicating that IB Acquisition is being referred to more favorably in the news media. Company Overall Sentiment GAMCO Investors Positive IB Acquisition Positive Is GAMI or IBAC more profitable? GAMCO Investors has a net margin of 27.99% compared to IB Acquisition's net margin of 0.00%. GAMCO Investors' return on equity of 35.78% beat IB Acquisition's return on equity.Company Net Margins Return on Equity Return on Assets GAMCO Investors27.99% 35.78% 23.60% IB Acquisition N/A N/A N/A Which has better earnings and valuation, GAMI or IBAC? GAMCO Investors has higher revenue and earnings than IB Acquisition. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGAMCO Investors$235.87M2.37$60.21M$2.608.87IB AcquisitionN/AN/AN/AN/AN/A Do insiders & institutionals have more ownership in GAMI or IBAC? 3.3% of GAMCO Investors shares are owned by institutional investors. 81.2% of GAMCO Investors shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the MarketBeat Community prefer GAMI or IBAC? GAMCO Investors and IB Acquisition both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformGAMCO InvestorsN/AN/AIB AcquisitionN/AN/A SummaryGAMCO Investors beats IB Acquisition on 7 of the 8 factors compared between the two stocks. Get IB Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for IBAC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IBAC vs. The Competition Export to ExcelMetricIB Acquisition IndustryUnclassified SectorNASDAQ ExchangeMarket Cap$139.88M$2.19B$123.13M$9.11BDividend YieldN/A13.99%5.15%4.00%P/E RatioN/A10.611.1613.06Price / SalesN/A177.3113.9676.04Price / CashN/A15.7691.8332.89Price / BookN/A2.281.014.58Net IncomeN/A$102.84M$1.73M$224.84M7 Day Performance0.20%1.84%-0.53%2.37%1 Month Performance0.69%0.96%23.81%4.40%1 Year PerformanceN/A11.38%29.04%20.10% IB Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IBACIB AcquisitionN/A$10.19+0.1%N/AN/A$139.88MN/A0.00N/APositive NewsGAMIGAMCO InvestorsN/A$22.80-2.1%N/A+24.4%$553.11M$235.87M8.77170Gap DownFPIFarmland Partners0.9839 of 5 stars$11.42+0.1%N/A+2.4%$550.14M$58.34M40.7930News CoveragePositive NewsPBTPermian Basin Royalty Trust0.4054 of 5 stars$11.77+0.8%N/A-19.9%$548.60M$37.74M15.09N/APositive NewsCHCTCommunity Healthcare Trust1.4897 of 5 stars$18.84+0.5%$21.25+12.8%-25.8%$532.08M$115.61M-209.3337GMREGlobal Medical REIT4.5715 of 5 stars$7.77+3.3%$11.25+44.8%-22.4%$519.06M$136.39M-388.3130Short Interest ↑VINPVinci Partners Investments4.2189 of 5 stars$9.45+1.6%$13.50+42.9%-9.2%$508.21M$567.43M15.24240ANSCAgriculture & Natural Solutions AcquisitionN/A$10.50+0.2%N/A+4.0%$452.81MN/A0.00N/AHigh Trading VolumeNLOPNet Lease Office Properties2.1428 of 5 stars$30.19+3.0%$46.00+52.4%+29.3%$446.36M$160.91M0.00N/AHigh Trading VolumeNETDNabors Energy Transition Corp. IIN/A$10.80-0.1%N/A+3.7%$411.75MN/A0.00N/APositive NewsBIOXBioceres Crop Solutions3.1344 of 5 stars$6.44-1.5%$12.13+88.3%-49.5%$404.74M$441.27M322.16500Short Interest ↑ Related Companies and Tools Related Companies GAMI Alternatives FPI Alternatives PBT Alternatives CHCT Alternatives GMRE Alternatives VINP Alternatives ANSC Alternatives NLOP Alternatives NETD Alternatives BIOX Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:IBAC) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IB Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share IB Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
